Rossari Biotech Ltd
BSE: 543213
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 516.14+14.5% | 450.66+7.4% | 419.51+14.7% | 365.76-14.3% | 426.65+15.9% | 368.28+9.6% | 335.99 |
| Other Income | 22.73+1892.0% | 1.14-18.3% | 1.40-19.8% | 1.74-27.3% | 2.40+138.2% | 1.01-6.9% | 1.08 |
| Total Income | 538.87+19.3% | 451.80+7.3% | 420.91+14.5% | 367.50-14.3% | 429.05+16.2% | 369.28+9.6% | 337.07 |
| EXPENSES | |||||||
| Expenditure | 465.32+13.0% | 411.70+8.6% | 378.94+14.1% | 332.06-13.8% | 385.19+17.4% | 328.02+9.3% | 300.16 |
| Tax | 18.82+98.6% | 9.47-11.6% | 10.72+16.4% | 9.21-19.9% | 11.49+8.1% | 10.63+12.0% | 9.49 |
| PROFIT | |||||||
| PBT | 73.55+83.4% | 40.10-4.5% | 41.97+18.4% | 35.44-19.2% | 43.86+6.3% | 41.26+11.8% | 36.91 |
| Net Profit | 54.73+78.7% | 30.63-2.0% | 31.25+19.1% | 26.23-18.9% | 32.36+5.7% | 30.63+11.7% | 27.42 |
| KEY METRICS | |||||||
| OPM % | 12.32%+1.14pp | 11.18%-0.84pp | 12.02%+0.01pp | 12.01%-0.22pp | 12.23%+3.93pp | 8.30%-2.69pp | 10.99% |
| NPM % | 10.16%+3.38pp | 6.78%-0.64pp | 7.42%+0.28pp | 7.14%-0.40pp | 7.54%-0.75pp | 8.29%+0.13pp | 8.16% |
| EPS | 9.88+78.7% | 5.53-2.0% | 5.64+19.0% | 4.74-19.0% | 5.85+5.8% | 5.53+1006.0% | 0.50 |
Corporate Events
Board MeetingROSSARI
202620Jul
Board Meeting
The 17th Annual General Meeting ("AGM") of the Company is sc…
BSE Filing ↗ Board MeetingROSSARI
202617Jan
Board Meeting
consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗ Board MeetingROSSARI
202515Oct
Board Meeting
Unaudited Financial Results for the quarter and half year en…
BSE Filing ↗ Board MeetingROSSARI
202519Jul
Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗ Board MeetingROSSARI
202521Jan
Board Meeting
Unaudited Financial Results .... months ended December 31, 2…
BSE Filing ↗ Board MeetingROSSARI
202420Jan
Board Meeting
Approval of Unaudited Financial Results (Standalone and Cons…
BSE Filing ↗ Board MeetingROSSARI
202321Oct
Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗